Related Experiment Video
Updated: Aug 9, 2026
06:59
Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Correlation between glucose disposal and amino acids levels in hyperthyroidism
N Barzilai1, E Karnieli, D Barzilai
1Endocrine Institute, Rambam Medical Center, Haifa, Israel.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|July 1, 1993
Summary
In hyperthyroidism, insulin still effectively lowers glucose and amino acids. The correlation between glucose disposal and amino acid reduction persists, even with altered insulin sensitivity.
Area of Science:
- Endocrinology
- Metabolic Research
- Human Physiology
Background:
- Insulin is recognized for its role in reducing plasma glucose and amino acid levels.
- Hyperthyroidism is characterized by altered insulin sensitivity, necessitating an investigation into its metabolic effects.
Purpose of the Study:
- To investigate whether the correlation between glucose disposal and amino acid levels is maintained in hyperthyroidism.
- To compare insulin's effects on glucose and amino acid metabolism in normal and hyperthyroid individuals.
Main Methods:
- Utilized the euglycemic hyperinsulinemic clamp technique in 5 normal and 5 hyperthyroid subjects.
- Measured glucose disposal rate and serum amino acid levels before and during insulin infusion.
Main Results:
- Insulin effectively decreased plasma amino acids in all subjects.
- Hyperthyroid subjects showed a greater mean amino acid decrease (50% vs. 35%) compared to normal subjects.
- The effective insulin doses for glucose disposal and amino acid reduction were higher in hyperthyroid subjects, but remained closely correlated.
Conclusions:
- The strong correlation between glucose disposal and decreased amino acid levels is preserved in hyperthyroidism.
- This study confirms the association between glucose disposal and amino acid levels across various insulin sensitivity states.
Related Concept Videos
01:26Glucose Absorption Into the Small Intestine
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...